Gene · 5932
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts. | FEBS Open Bio | 2023 | 37499040 | PubTator, text mining | PubMed |
| CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules. | Zhongguo Fei Ai Za Zhi | 2023 | 37488082 | PubTator, text mining | PubMed |
| Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients. | Sci Rep | 2023 | 37474724 | PubTator, text mining | PubMed |
| Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. | Nucleic Acids Res | 2023 | 37470997 | PubTator, text mining | PubMed |
| ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms. | Cell Rep | 2023 | 37454295 | PubTator, text mining | PubMed |
| The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork. | Int J Mol Sci | 2023 | 37445667 | PubTator, text mining | PubMed |
| Genetic Primary Microcephalies: When Centrosome Dysfunction Dictates Brain and Body Size. | Cells | 2023 | 37443841 | PubTator, text mining | PubMed |
| RHINO directs MMEJ to repair DNA breaks in mitosis. | Science | 2023 | 37440612 | PubTator, text mining | PubMed |
| DNA double-strand break genetic variants in patients with premature ovarian insufficiency. | J Ovarian Res | 2023 | 37430352 | PubTator, text mining | PubMed |
| PARP inhibitors: enhancing efficacy through rational combinations. | Br J Cancer | 2023 | 37430137 | PubTator, text mining | PubMed |
| An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly. | Front Cell Dev Biol | 2023 | 37427375 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer. | Res Sq | 2023 | 37398210 | PubTator, text mining | PubMed |
| Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignancies. | Genes Dis | 2023 | 37396510 | PubTator, text mining | PubMed |
| Treatment mechanism of immune triad from the repurposing drug against COVID-19. | Transl Med Aging | 2023 | 37388715 | PubTator, text mining | PubMed |
| High Expression of MRE11A Is Associated with Shorter Survival and a Higher Risk of Death in CRC Patients. | Genes (Basel) | 2023 | 37372450 | PubTator, text mining | PubMed |
| Microcephaly, Short Stature, Intellectual Disability, Speech Absence and Cataract Are Associated with Novel Bi-Allelic Missense Variant in RTTN Gene: A Seckel Syndrome Case Report. | Children (Basel) | 2023 | 37371259 | PubTator, text mining | PubMed |
| PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities. | Front Pharmacol | 2023 | 37351512 | PubTator, text mining | PubMed |
| Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345145 | PubTator, text mining | PubMed |
| Systematic analysis of the molecular and biophysical properties of key DNA damage response factors. | Elife | 2023 | 37341699 | PubTator, text mining | PubMed |
| Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy. | Res Sq | 2023 | 37333340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5932/papers?page=12